Report Detail

Pharma & Healthcare Global Cas Nuclease Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4528285
  • |
  • 12 April, 2023
  • |
  • Global
  • |
  • 101 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Cas Nuclease market size was valued at USD 150.8 million in 2022 and is forecast to a readjusted size of USD 787 million by 2029 with a CAGR of 26.6% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The main manufacturers of Cas nuclease include Thermo Fisher Scientific, GenScript and Integrated DNA Technologies, Inc., etc. The top three manufacturers account for about 45% of the share. North America is the largest market with about 44% share, followed by Europe and China with about 35% and 8% of the market. Cas9 is the largest segment with an 85% share. Gene editing cell line construction was the largest application with about 40% share.
This report is a detailed and comprehensive analysis for global Cas Nuclease market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Cas Nuclease market size and forecasts, in consumption value ($ Million), 2018-2029
Global Cas Nuclease market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Cas Nuclease market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Cas Nuclease market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cas Nuclease
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cas Nuclease market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, GenScript, Integrated DNA Technologies, Inc., Aldevron and Merck, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Cas Nuclease market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Cas9
Cas12
Cas13
Others
Market segment by Application
Gene Editing Cell Line Construction
Animal Models
Bioagriculture
Gene Therapy
Other
Market segment by players, this report covers
Thermo Fisher Scientific
GenScript
Integrated DNA Technologies, Inc.
Aldevron
Merck
Horizon Discovery
Agilent
OriGene Technologies, Inc
New England Biolabs
NIPPON GENE CO., LTD.
Novoprotein
Applied Biological Materials Inc. (abm)
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cas Nuclease product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cas Nuclease, with revenue, gross margin and global market share of Cas Nuclease from 2018 to 2023.
Chapter 3, the Cas Nuclease competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Cas Nuclease market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Cas Nuclease.
Chapter 13, to describe Cas Nuclease research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Cas Nuclease
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Cas Nuclease by Type
    • 1.3.1 Overview: Global Cas Nuclease Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Cas Nuclease Consumption Value Market Share by Type in 2022
    • 1.3.3 Cas9
    • 1.3.4 Cas12
    • 1.3.5 Cas13
    • 1.3.6 Others
  • 1.4 Global Cas Nuclease Market by Application
    • 1.4.1 Overview: Global Cas Nuclease Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Gene Editing Cell Line Construction
    • 1.4.3 Animal Models
    • 1.4.4 Bioagriculture
    • 1.4.5 Gene Therapy
    • 1.4.6 Other
  • 1.5 Global Cas Nuclease Market Size & Forecast
  • 1.6 Global Cas Nuclease Market Size and Forecast by Region
    • 1.6.1 Global Cas Nuclease Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Cas Nuclease Market Size by Region, (2018-2029)
    • 1.6.3 North America Cas Nuclease Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Cas Nuclease Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Cas Nuclease Market Size and Prospect (2018-2029)
    • 1.6.6 South America Cas Nuclease Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Cas Nuclease Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Thermo Fisher Scientific
    • 2.1.1 Thermo Fisher Scientific Details
    • 2.1.2 Thermo Fisher Scientific Major Business
    • 2.1.3 Thermo Fisher Scientific Cas Nuclease Product and Solutions
    • 2.1.4 Thermo Fisher Scientific Cas Nuclease Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.2 GenScript
    • 2.2.1 GenScript Details
    • 2.2.2 GenScript Major Business
    • 2.2.3 GenScript Cas Nuclease Product and Solutions
    • 2.2.4 GenScript Cas Nuclease Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 GenScript Recent Developments and Future Plans
  • 2.3 Integrated DNA Technologies, Inc.
    • 2.3.1 Integrated DNA Technologies, Inc. Details
    • 2.3.2 Integrated DNA Technologies, Inc. Major Business
    • 2.3.3 Integrated DNA Technologies, Inc. Cas Nuclease Product and Solutions
    • 2.3.4 Integrated DNA Technologies, Inc. Cas Nuclease Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Integrated DNA Technologies, Inc. Recent Developments and Future Plans
  • 2.4 Aldevron
    • 2.4.1 Aldevron Details
    • 2.4.2 Aldevron Major Business
    • 2.4.3 Aldevron Cas Nuclease Product and Solutions
    • 2.4.4 Aldevron Cas Nuclease Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Aldevron Recent Developments and Future Plans
  • 2.5 Merck
    • 2.5.1 Merck Details
    • 2.5.2 Merck Major Business
    • 2.5.3 Merck Cas Nuclease Product and Solutions
    • 2.5.4 Merck Cas Nuclease Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Merck Recent Developments and Future Plans
  • 2.6 Horizon Discovery
    • 2.6.1 Horizon Discovery Details
    • 2.6.2 Horizon Discovery Major Business
    • 2.6.3 Horizon Discovery Cas Nuclease Product and Solutions
    • 2.6.4 Horizon Discovery Cas Nuclease Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Horizon Discovery Recent Developments and Future Plans
  • 2.7 Agilent
    • 2.7.1 Agilent Details
    • 2.7.2 Agilent Major Business
    • 2.7.3 Agilent Cas Nuclease Product and Solutions
    • 2.7.4 Agilent Cas Nuclease Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Agilent Recent Developments and Future Plans
  • 2.8 OriGene Technologies, Inc
    • 2.8.1 OriGene Technologies, Inc Details
    • 2.8.2 OriGene Technologies, Inc Major Business
    • 2.8.3 OriGene Technologies, Inc Cas Nuclease Product and Solutions
    • 2.8.4 OriGene Technologies, Inc Cas Nuclease Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 OriGene Technologies, Inc Recent Developments and Future Plans
  • 2.9 New England Biolabs
    • 2.9.1 New England Biolabs Details
    • 2.9.2 New England Biolabs Major Business
    • 2.9.3 New England Biolabs Cas Nuclease Product and Solutions
    • 2.9.4 New England Biolabs Cas Nuclease Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 New England Biolabs Recent Developments and Future Plans
  • 2.10 NIPPON GENE CO., LTD.
    • 2.10.1 NIPPON GENE CO., LTD. Details
    • 2.10.2 NIPPON GENE CO., LTD. Major Business
    • 2.10.3 NIPPON GENE CO., LTD. Cas Nuclease Product and Solutions
    • 2.10.4 NIPPON GENE CO., LTD. Cas Nuclease Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 NIPPON GENE CO., LTD. Recent Developments and Future Plans
  • 2.11 Novoprotein
    • 2.11.1 Novoprotein Details
    • 2.11.2 Novoprotein Major Business
    • 2.11.3 Novoprotein Cas Nuclease Product and Solutions
    • 2.11.4 Novoprotein Cas Nuclease Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Novoprotein Recent Developments and Future Plans
  • 2.12 Applied Biological Materials Inc. (abm)
    • 2.12.1 Applied Biological Materials Inc. (abm) Details
    • 2.12.2 Applied Biological Materials Inc. (abm) Major Business
    • 2.12.3 Applied Biological Materials Inc. (abm) Cas Nuclease Product and Solutions
    • 2.12.4 Applied Biological Materials Inc. (abm) Cas Nuclease Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Applied Biological Materials Inc. (abm) Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Cas Nuclease Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Cas Nuclease by Company Revenue
    • 3.2.2 Top 3 Cas Nuclease Players Market Share in 2022
    • 3.2.3 Top 6 Cas Nuclease Players Market Share in 2022
  • 3.3 Cas Nuclease Market: Overall Company Footprint Analysis
    • 3.3.1 Cas Nuclease Market: Region Footprint
    • 3.3.2 Cas Nuclease Market: Company Product Type Footprint
    • 3.3.3 Cas Nuclease Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Cas Nuclease Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Cas Nuclease Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Cas Nuclease Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Cas Nuclease Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Cas Nuclease Consumption Value by Type (2018-2029)
  • 6.2 North America Cas Nuclease Consumption Value by Application (2018-2029)
  • 6.3 North America Cas Nuclease Market Size by Country
    • 6.3.1 North America Cas Nuclease Consumption Value by Country (2018-2029)
    • 6.3.2 United States Cas Nuclease Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Cas Nuclease Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Cas Nuclease Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Cas Nuclease Consumption Value by Type (2018-2029)
  • 7.2 Europe Cas Nuclease Consumption Value by Application (2018-2029)
  • 7.3 Europe Cas Nuclease Market Size by Country
    • 7.3.1 Europe Cas Nuclease Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Cas Nuclease Market Size and Forecast (2018-2029)
    • 7.3.3 France Cas Nuclease Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Cas Nuclease Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Cas Nuclease Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Cas Nuclease Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Cas Nuclease Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Cas Nuclease Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Cas Nuclease Market Size by Region
    • 8.3.1 Asia-Pacific Cas Nuclease Consumption Value by Region (2018-2029)
    • 8.3.2 China Cas Nuclease Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Cas Nuclease Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Cas Nuclease Market Size and Forecast (2018-2029)
    • 8.3.5 India Cas Nuclease Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Cas Nuclease Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Cas Nuclease Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Cas Nuclease Consumption Value by Type (2018-2029)
  • 9.2 South America Cas Nuclease Consumption Value by Application (2018-2029)
  • 9.3 South America Cas Nuclease Market Size by Country
    • 9.3.1 South America Cas Nuclease Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Cas Nuclease Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Cas Nuclease Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Cas Nuclease Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Cas Nuclease Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Cas Nuclease Market Size by Country
    • 10.3.1 Middle East & Africa Cas Nuclease Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Cas Nuclease Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Cas Nuclease Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Cas Nuclease Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Cas Nuclease Market Drivers
  • 11.2 Cas Nuclease Market Restraints
  • 11.3 Cas Nuclease Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Cas Nuclease Industry Chain
  • 12.2 Cas Nuclease Upstream Analysis
  • 12.3 Cas Nuclease Midstream Analysis
  • 12.4 Cas Nuclease Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Cas Nuclease. Industry analysis & Market Report on Cas Nuclease is a syndicated market report, published as Global Cas Nuclease Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Cas Nuclease market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,745.72
    4,118.58
    5,491.44
    3,201.60
    4,802.40
    6,403.20
    539,991.60
    809,987.40
    1,079,983.20
    290,580.00
    435,870.00
    581,160.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report